Bottom line
What is EMOAX's expense ratio?
EMOAX's expense ratio is 0.92%, or about $92 a year on every $10,000 invested. That is more expensive than 78% of municipal bond funds we track (median 0.63%). This share class also charges a front-end sales load of up to 3.25%, taken from your investment when you buy. Its expense ratio includes a 0.25% 12b-1 marketing fee.
Updated Nov 25, 2025
EMOAX fee table
| Net expense ratio | 0.92% |
|---|---|
| Gross expense ratio | 0.97% |
| Management fee | 0.59% |
| 12b-1 (distribution) fee | 0.25% |
| Other expenses | 0.13% |
| Fee waiver / reimbursement | -0.05% |
| Max front-end sales load | 3.25% |
| Max deferred sales charge | 0% |
Source: Fund prospectus fee table, filed Nov 25, 2025
What EMOAX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| EMOAX | $416 | $619 | $839 | $1,472 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 0.92% expense ratio costs roughly $51,300 in lost growth, versus about $36,000 for the median municipal bond fund (0.63%).